{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:52:46Z","timestamp":1789131166054,"version":"build-2803163510"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.2169\/internalmedicine.3372-19","type":"journal-article","created":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T22:03:24Z","timestamp":1570399404000},"page":"439-443","source":"Crossref","is-referenced-by-count":3,"title":["A Non-smoking Woman with Anti-phospholipid Antibodies Proved to Have Thromboangiitis Obliterans"],"prefix":"10.2169","volume":"59","author":[{"given":"Natsuki","family":"Shima","sequence":"first","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kokuzawa","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Nagatani","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"},{"name":"Department of Rheumatology, Tochigi Medical Center Shimotsuga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Tochigi Medical Center Shimotsuga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Minota","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Olin JW, Shih A. Thromboangiitis obliterans (Buerger's disease). Curr Opin Rheumatol 18: 18-24, 2006.","DOI":"10.1097\/01.bor.0000198000.58073.aa"},{"key":"2","unstructured":"2. Mills JL Sr. Buerger's disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 16: 179-189, 2003."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 343: 864-869, 2000.","DOI":"10.1056\/NEJM200009213431207"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Heper G, Kose S, Akkoc O, Amasyali B, Kilic A. Two female nonsmoker Buerger's disease cases with anticardiolipin autoantibodies and a poor prognosis. Int Heart J 46: 563-569, 2005.","DOI":"10.1536\/ihj.46.563"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Piazza G, Creager MA. Thromboangiitis obliterans. Circulation 121: 1858-1861, 2010.","DOI":"10.1161\/CIRCULATIONAHA.110.942383"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hernandez-Rodriguez J, Alba MA, Prieto-Gonzalez S, Cid MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun 48-49: 84-89, 2014.","DOI":"10.1016\/j.jaut.2014.01.029"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Maslowski L, McBane R, Alexewicz P, Wysokinski WE. Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med 7: 259-264, 2002.","DOI":"10.1191\/1358863x02vm452oa"},{"key":"8","unstructured":"8. Lie JT. Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort. Lupus 5: 368-371, 1996."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12: 530-534, 2003.","DOI":"10.1191\/0961203303lu394oa"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Llamas-Velasco M, Alegria V, Santos-Briz A, Cerroni L, Kutzner H, Requena L. Occlusive Nonvasculitic Vasculopathy. Am J Dermatopathol 39: 637-662, 2017.","DOI":"10.1097\/DAD.0000000000000766"},{"key":"11","unstructured":"11. Lie JT. Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both? J Rheumatol 16: 713-715, 1989."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rivera-Chavarria IJ, Brenes-Gutierrez JD. Thromboangiitis obliterans (Buerger's disease). Ann Med Surg (Lond) 7: 79-82, 2016.","DOI":"10.1016\/j.amsu.2016.03.028"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Park HS, Cho KH, Kim KL, Kim DK, Lee T. Reduced circulating endothelial progenitor cells in thromboangiitis obliterans (Buerger's disease). Vasc Med 18: 331-339, 2013.","DOI":"10.1177\/1358863X13513935"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/3\/59_3372-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T03:43:33Z","timestamp":1580528613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/3\/59_3372-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3372-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}